Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

There are no files associated with this record.

Title Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Author Chaturvedi, Nish; Porta, Massimo; Klein, Ronald; Orchard, Trevor; Fuller, John; Parving, Hans-Henrik; Bilous, Rudy; Sjolie, Anne Katrin; Fox, Ywonne; George, Michael; Svensson, Anders; Hainer, James; Warnold, Ingrid; Agardh, Carl-David; Bonnici, Francois; Charbonnel, Bernard; Cooper, Mark; Dedov, Ivan; Gardiner, Robert; Gomis, Ramon; Ilkova, Hasan; Katsilambros, Nicholas; Kerenyi, Zsuzsa; Martin, Stephan; Massin, Pascale; Pirags, Valdis; Raz, Itamar; Rusavy, Zdenek; Schernthaner, Guntram; Shestakova, Marina; Strojek, Krzysztof; Olofsson, Bertil; Malm, Anders; Wissmar, Jenny; Brayshaw, Nigel; Wedel, Hans; Wilhelmsen, Lars; Bird, Alan; Price, Graham; Adler-Ekholm, Elisabeth; Aldington, Stephen; Dahl, Magnus; Deveney, Aaron; Karlsten, Eva; Levins, Philippa; Lipinski, Helen; Prenter, Carol; Walkey, Helen; Walters, Nicola; Chen, Roger; Colman, Peter; Davoren, Peter Michael; Donelly, Thomas; al, et
Year Published 2008
Publisher The Lancet Publishing Group
Citation Lancet, Vol. 372, pp. 1394-1402
Peer Reviewed Yes
Published Yes
Publisher URI http://www.thelancet.com/
Alternative URI http://dx.doi.org/10.1016/S0140-6736(08)61412-9
Faculty Griffith Health Faculty
Publication Type Journal Articles (Refereed Article)

Show full item record

Griffith University copyright notice